Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.

Vinge has advised Bolero in connection with sale of shares in Ambea AB (publ)

Vinge has advised Bolero Holdings S.à r.l. in connection with the sale of shares in Ambea AB (publ) through an accelerated bookbuilding process carried out on 26 August 2025.

Vinge has advised EQT IX in connection with sale of shares in Beijer Ref AB (publ)

Vinge has advised EQT IX (”EQT”) in connection with the sale of shares in Beijer Ref AB (publ) through an accelerated bookbuilding process carried out on 26 August 2025.

Vinge advises Intrum on its EUR 4.48 billion recapitalisation transaction

Intrum AB and its subsidiaries have completed a comprehensive and strategic recapitalisation transaction aimed at strengthening the company's balance sheet and securing its long-term financial stability. The transaction involves a restructuring of Intrum's existing debt portfolio of approximately EUR 4.48 billion and includes, among other things, an extension of loan maturities, write-downs of existing debt instruments, the injection of new capital from certain of the company's noteholders, and a share issue to existing noteholders. The recapitalisation transaction was implemented through a pre-packaged Chapter 11 process in the United States and a Swedish company reorganisation.

Vinge advises Neptuniplan Maritime in financing of ANCS acquisition

Vinge has advised Neptuniplan Maritime Holding AB in connection with entering into a more than EUR 133 000 000 facilities agreement with Citibank, Danske Bank and Nordea for the purpose of, among other things, financing its acquisition of Wärtsilä’s Automation, Navigation and Control Systems (ANCS) business. Operations will be continuing under NACOS Marine, who provides, among other things, advanced solutions in vessel navigation, automation, and control systems, as well as adaptive autopilots and Guidance Marine, a leader in position reference sensor technology for dynamic positioning and maritime safety.

Vinge has advised HealthCap on the establishment of HealthCap IX

HealthCap IX has held its final closing, raising total commitments in excess of the target from a diverse investor base comprising established institutions, pension funds, and renowned investors within the life sciences sector. The strong support reflects continued confidence in HealthCap’s strategy and proven track record.

Vinge advises MAAG Gear with its MEUR 18.5 refinancing

Vinge has advised MAAG Gear in connection with entering into a EUR 18 500 000 facility agreement with Danske Bank A/S for the purpose of, among other things, refinancing its previous credit. MAAG Gear is a leading manufacturer of industrial gear solutions for cement and mining applications with a comprehensive product portfolio and global aftermarket services offering.

Vinge has advised Direktronik in conjunction with the acquisition of Qvintus

Direktronik, a subsidiary of Lagercrantz Group, has acquired all shares in Qvintus.

Vinge advises Sobro in conjunction with investment in vChain

vTrade, together with its subsidiary vChain, has decided to broaden its shareholder base with Sobro as a new owner and majority shareholder. Founder Carl-Henrik Lundh will continue as CEO and significant shareholder.

Vinge has advised on the sale of Mora Bygg to Pinerock Group

Pinerock Group has acquired Mora Bygg AB with its subsidiaries Helob Bygg AB and Mora Golv & Kakel AB.

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.